Aptamers Market Size, Share, Growth Analysis, By Type(DNA Aptamers), By Technology(SELEX, Other Technologies, Research & Development, Others), By Application(Therapeutics Development, Research & Development, Diagnostics, Other Applications), By End User(Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Contract Research Organizations, Other End Users), By Region - Industry Forecast 2024-2031

Drivers

High Demand for Targeted Therapeutics 

• Growing investments in drug delivery technology development have led to the creation of targeted therapeutics. Acceptance of these targeted therapeutics is increasing rapidly around the world as they eliminate the possibility of unexpected side effects. Aptamers are being used in the creation of these therapeutics thereby driving market growth as well.  

High Use in Diagnostics 

• The high specificity of aptamers has allowed them to be extensively used in multiple diagnostic applications. The ability of aptamers to detect a range of biomarkers is what helps their application scope in diagnostics. Integration of aptamers with biosensors, lateral flow assays, and ELISA-like platforms for early diagnosis will help market development in the future.  

Restraints 

Short Half-life 

• Aptamers have a very short half-life ranging from minutes to hours. This short half-life makes it highly difficult to find practical applications for the same. Managing this short half-life and keeping the aptamers characteristics intact without degradation is a challenge that is expected to slow down their demand over the coming years. 

Limited Awareness and Acceptance 

• The use of aptamers is not as extensive as other biological materials and components as there is a substantial lack of knowledge regarding aptamers. Many researchers, clinicians, and companies are more familiar with antibodies, which is why they favor the use of the same and this limits the demand for aptamers.